Achieving high quality Spirometry data in hybrid and decentralized trials
In this webinar, Clario Respiratory Experts and guest speaker Dr. Kai Beeh will discuss the challenges in generating high quality data in virtual or decentralized trials if patients are not properly coached and supported by experienced site personnel. Clario will share how to unlock new possibilities in virtual trials.
Speakers
Dawn Patterson
Director, Respiratory Solutions at Clario
After spending 18 years as a respiratory therapist with Taylor Hospital, Dawn Patterson began her nearly decade-long career with Clario supervising and training clinical specialists in pulmonary function data analysis while designing and monitoring new processes and procedures that would increase the productivity, efficiency, and quality of the respiratory team overall.
Today, in addition to providing in-depth strategic direction for both the respiratory and sales teams, Dawn also interacts with and supports customers with informative presentations and seminars on the applications of new products and services.
Kevin McCarthy
Director, Respiratory Solutions at Clario
Kevin McCarthy has been working in the field of lung function testing since 1973. He was the manager of the Pulmonary Function Laboratories at the Cleveland Clinic Health System for nearly 40 years, retiring in 2016. Kevin’s research experience includes managing the pulmonary function quality control in two NIH-funded registries: patient with severe A1AT deficiency and LAM Registry and was the site manager at Cleveland Clinic for the NETT study.
Kevin has published extensively on the topic of pulmonary function testing. He is a current member of the ATS PFT Committee and the ATS/ERS Task Force to update the standards for Lung Volume testing. He was a member of the ATS/ERS Task Force that updated the standards for Spirometry in 2019. Kevin is also a member of the faculty that presents the annual MGC Diagnostics Cardiorespiratory Diagnostics Seminar which has been providing excellent pulmonary function education for over 25 years.
Kevin has always been passionate about the quality of pulmonary function measurements. This passion has now moved to the clinical trial world where data quality is critical if these measurements are to accurately answer the questions we are asking. He is now the Director of Respiratory Solutions at Clario for the US West Coast and Australia.
Phil Lake, PhD
Senior Director, Respiratory Solutions at Clario
Phil Lake, PhD is a respiratory specialist at Clario who supports clients all around the world. Phil has held a variety of roles in drug development for nearly 20 years, predominantly focused on respiratory trials.
Prior to Clario, Phil held positions at SmithKline Beecham and GlaxoSmithKline. There, he worked on a number of anti-inflammatory agents, dual and triple combination therapy, monoclonal antibody studies, anti-infectives and some of the largest mechanistic studies looking at biomarkers within sputum and biopsy samples. He also has experience supporting a number of CROs as a respiratory specialist and as the head of project management. For the last 10 years, he has concentrated extensively on rare respiratory diseases, including Cystic Fibrosis and Idiopathic Pulmonary Fibrosis, covering a variety of drug mechanisms and medical devices. Phil was pivotal to some of the first centralised over read studies and is committed to driving improvements in lung function testing.
He completed his training at University College Cardiff and Southampton University.
Priv.-Doz. Dr. Kai-Michael Beeh
Founder and Medical Director of insaf Respiratory Research Institute Wiesbaden, Germany
Dr. Beeh was born in 1971, in Cuxhaven, Germany. After studies in Medicine and Art History in Frankfurt, Germany, he was clinically trained at Mainz University Hospital from 1997 to 2004. He performed basic research studies on lung inflammation at the National Heart and Lung Institute, Imperial College, London, UK in 2000, and received board certifications in Internal Medicine (2003) and Pulmonary Medicine (2004).
In 2004 he co-founded the insaf Respiratory Research Institute in Wiesbaden (GER), where he currently works as Medical Director. In this position he has designed and conducted more than 100 clinical trials in asthma, COPD and allergies, acting as Principal or Coordinating Investigator. In 2009 he founded Aereon Consulting, a scientific service company, also located in Wiesbaden. Dr. Beeh received a degree in healthcare “Market Access Management” from the European Business School, Oestrich Winkel, in 2015. From 2021 onwards he operates a private practice for Pulmonology in Wiesbaden.
Dr. Beeh received the venia legendi for Internal Medicine from the medical faculty of the University of Mainz in 2004, and serves as external lecturer (‘Privatdozent’; adjunct Professor) at Mainz University Hospital since then.
Dr. Beeh is the author of the popular international non-fiction book “Die atemberaubende Welt der Lunge” (The breathtaking World of the Lung), published by Random House in October 2018 in multiple countries and languages globally. He is Editor of Pulmonary Therapy, Associate Editor of Advances in Therapy and has published or co-authored over 100 peer-reviewed articles on pathophysiology and pharmacotherapy of chronic airway diseases, including two publications in the New England Journal of Medicine. He has also edited and co-authored a textbook on COPD exacerbations in 2014, and reviews scientific articles for biomedical journals such as the European Respiratory Journal, Lancet Respiratory Medicine, and others. Dr. Beeh is a member of the German Society of Pneumology (DGP) and German Society for Market Access (DFGMA).